Viewing Study NCT03894150


Ignite Creation Date: 2025-12-24 @ 5:13 PM
Ignite Modification Date: 2025-12-24 @ 5:13 PM
Study NCT ID: NCT03894150
Status: COMPLETED
Last Update Posted: 2024-05-14
First Post: 2019-03-26
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module